Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

MNPRMNPR
7 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in MONOPAR THERAPEUTICS INC

Yes. RA Capital Management holds 667,207 shares of MNPR (Monopar Therapeutics), worth $61.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held MNPR since Q4 2024, across 7 quarterly 13F filings. MNPR is 0.5% of RA Capital Management's reported 13F portfolio.

Current Value

$61.8M

Current Shares

667,207

Total Value Change

+$50.5M

Total Shares Change

+156,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
667,207
0.0%
$61.8M0.5%$92.59
0
2026-Q1
Unchanged
667,207
0.0%
$36.6M0.4%$51.88
0
2025-Q4
Increased
667,207
+30.5%
$43.6M0.4%$65.07
44
2025-Q3
Unchanged
511,207
0.0%
$41.8M0.5%$75.90
0
2025-Q2
Unchanged
511,207
0.0%
$18.3M0.3%$33.60
0
2025-Q1
Unchanged
511,207
0.0%
$18.6M0.3%$40.33
0
2024-Q4
New
511,207
-
$11.2M0.1%$23.85
46

Other major holders of MNPR: Jupiter Topco LLC, Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used